Cardiovascular Stents Market Regional Analysis by Key Players, Report Overview, Share, Size Forecast to 2025

Pune, India -- (SBWire) -- 06/26/2019 --In 2017, Coronary Stents Surgery was the most common treatment among Cardiovascular patients with a market share of 66.9%. The rising number of cardiovascular diseases worldwide is expected to drive the global market, as per analysts at Fortune Business Insights.

Besides this, huge investments made by market players in research and development on environmental and decomposable coronary stents is also anticipated to boost the market.

Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/cardiovascular-stents-market-100061

Increasing incidence of Cardiovascular Diseases worldwide is creating growth opportunities for the Global Cardiovascular Stents Market, predicts Fortune Business Insights in their new study. The study is titled, "Cardiovascular Stents Market: Global Market Analysis, Insights and Forecasts, 2018 – 2025". As per Fortune Business Insights, the market is prognosticated to exhibit 6.6% CAGR and reach a valuation of US$ 13,100.2 Mn by 2025 from US$ 7,838.9 Mn in 2017.

Some of the leading companies in the global Cardiovascular Stents Market are

- Medtronic
- Cardinal Health
- Abbott
- Boston Scientific
- Biotronik
- Cook
- CR Bard
- MicroPort Scientific Corp
- Terumo Medical Corporation
- BKK. B. Braun Melsungen AG

The Global Cardiovascular Stents Market derives growth from a number of factors such as increasing focus on research and development (R&D), increasing investment from leading companies towards R&D. Besides this, increasing regulatory approvals from organizations such as the Food and Drug Administration (FDA) have contributed significantly to the global Cardiovascular Stents Market

Increasing Number of Cardiovascular Cases to Fuel Demand in Market

Unhealthy lifestyle and irregular eating habits of people have led to having increased the prevalence of health-related concerns, including chronic diseases such as diabetes, obesity, and heart disorders. The surging cases of heart disorder are continuously fueling the demand for treating heart problems including angioplasty, which ultimately increased the demand for cardiovascular stents.

However, the market may face challenges due to the presence of alternative treatment methods for vascular diseases. Again, the complexity of cardiovascular stent implantation may cause patients to opt for other treatment options and this may restrict growth in the market. Besides this, the incident of product recalls and failures may also hamper the market in the future.

Furthermore, newer drug discoveries as a result of the emphasis on R&D have favored the growth of the global Cardiovascular Stents Market and are likely to boost the market in the coming years. Backed by contributions from the government as well as private organizations, the global Cardiovascular Stents Market is likely to gain traction in the coming years.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Key Cardiovascular Diseases- Key Countries, 2017
4.2 Health Reimbursement Scenario- Key Countries
4.3 Regulatory Scenario- Key Countries
4.4 Pricing Analysis
4.5 Recent Industry Developments - Partnerships, Mergers & Acquisitions
5. Global Cardiovascular Stents Market Analysis, Insights and Forecast,2014-2025
5.1. Key Findings/ Summary
5.2. Market Analysis, Insights and Forecast – By Procedure Type
5.2.1 Coronary Stenting
5.2.2 Peripheral Stenting
5.3. Market Analysis, Insights and Forecast – By Stent Type
5.3.1 Drug Eluting Stents (DES)
5.3.2 Bioresorbable Stents
5.3.3 Bare Metal Stents
5.3.4 Others
5.4 Market Analysis, Insights and Forecast – By Disease Indication
5.4.1 Venous Diseases
5.4.2 Arterial Diseases

Alpine Stent to Open Growth Opportunities for Market in the Asia Pacific

The cardiovascular stents market in North America was emerged dominant and was valued at US$ 2,344.9 Mn in 2017. This is mainly due to the presence of better medical facilities and skilled professionals in the developed nations of Canada and the U.S. North America is likely to remain dominant in the coming years as well on account of ongoing clinical trials on novel stents in the U.S. and various regulatory approvals on cardiovascular stents.

The market for cardiovascular stents in the Asia Pacific is likely to show growth at a higher rate on account of the improved distribution of cardiovascular stents in emerging economies such as China and India. In order to improve their accessibility, price capping of stents is introduced in these developing nations and this will help the market gain momentum. Thus, Asia Pacific is likely to register itself as the fastest growing region in the during the forecast tenure.

Various companies operating in the global cardiovascular stents market are B. Braun Melsungen AG, Cardinal Health, C. R. Bard, Inc., Terumo Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, and others. Major vendors are focusing on investing in clinical studies and research and development of better stents. At present, Boston Scientific Corporation, Abbott, and Medtronic are leading the market.

Get Customization:
https://www.fortunebusinessinsights.com/enquiry/customization/cardiovascular-stents-market-100061